- Tytuł:
- ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.
- Autorzy:
- Źródło:
-
Blood cancer journal [Blood Cancer J] 2019 May 21; Vol. 9 (6), pp. 51. Date of Electronic Publication: 2019 May 21. - Typ publikacji:
- Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Biomarkers, Tumor*
Polymorphism, Single Nucleotide*
Antineoplastic Agents, Immunological/*therapeutic use
Gemtuzumab/*therapeutic useLeukemia, Myeloid, Acute /*drug therapyLeukemia, Myeloid, Acute /*genetics
ATP Binding Cassette Transporter, Subfamily B/genetics ; Adolescent ; Adult ; Alleles ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Child ; Child, Preschool ; Female ; Gemtuzumab/administration & dosage ; Gemtuzumab/adverse effects ; Genotype ; Humans ; Infant ; Infant, Newborn ;Leukemia, Myeloid, Acute /diagnosis ;Leukemia, Myeloid, Acute /mortality ; Male ; Prognosis ; Recurrence ; Treatment Outcome ; Young Adult
Czasopismo naukowe